Terrapinn's flagship European vaccine event, drawing 2,000+ attendees, 280 speakers and 150+ exhibitors across three days (19 Oct workshop day, 20-21 Oct conference and exhibition). The programme spans the whole vaccine value chain: R&D, mRNA and viral-vector platforms, adjuvants, bioprocessing and manufacturing, clinical trials, regulatory and pandemic preparedness, plus a dedicated Supply & Logistics track. The 2026 edition runs at Amsterdam's RAI, a move from prior Barcelona editions.
The Supply & Logistics track deals directly with vaccine supply demand and last-mile delivery technologies, where distribution and cold-chain strategy for temperature-sensitive biologics is worked out alongside manufacturers and regulators. Scale-up, pandemic-preparedness and manufacturing sessions shape how vaccines are produced, moved and kept within temperature spec globally, which is the substance of vaccine cold chain.
Vaccine developers, bioprocessing and manufacturing leads, supply-chain and logistics directors, and clinical, regulatory and quality staff, alongside government and global-health agency representatives. Company types run from large pharma (Pfizer, Moderna, Sanofi, GSK) and biotech to CDMOs, academia and bodies such as the WHO and EMA. Seniority skews to heads-of, VPs and directors.
Be the first to raise your hand.